Parithera

medical devices

About

Parithera is a biotechnology startup based in the US and Switzerland, dedicated to enhancing precision oncology through innovative AI-driven liquid biopsy technologies. The company originated as a spin-off from ETH Zürich and EPFL, collaborating with CSEM and CHUV. Parithera focuses on providing minimally invasive diagnostics that help clinicians make informed cancer treatment decisions by analyzing treatment resistance and tumor heterogeneity. The company operates a dual business model, with a hardware division that produces proprietary microfluidic devices for capturing single cells and an AI platform aimed at long-term growth in the biopharma market. Parithera's key products include ExTrace, an automated liquid biopsy platform that captures circulating tumor cells with high purity, and ExPlore, an AI-powered software suite that analyzes sequencing data to provide actionable insights. Parithera targets biopharma companies and aims to support clinical and research applications in oncology, ultimately striving to improve patient outcomes through personalized treatment strategies.

Technologies

Gmail Google Apps Microsoft Office 365 Mobile Friendly IoT Android Node.js Remote Render AI Xamarin

Keywords

medical equipment manufacturing cancer mutation analysis oncology solutions molecular profiling cancer treatment molecular data analysis biomedical technology molecular diagnostics therapeutic development clinical research b2b precision diagnostics genomic sequencing genetic analysis personalized treatment algorithms personalized medicine healthcare targeted treatment development genetic data analysis cancer genomics biotech innovation medical research research and development in the physical engineering and life sciences diagnostic tools precision oncology oncology biomarkers oncology diagnostics services

Location

Lausanne, Vaud, Switzerland

Related Companies

Companies in the same industry